de Boer SM - Search Results

1

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.

de Boer SM, Kortekaas J, Antonis AF, Kant J, van Oploo JL, Rottier PJ, Moormann RJ, Bosch BJ. de Boer SM, et al. Vaccine. 2010 Mar 8;28(11):2330-9. doi: 10.1016/j.vaccine.2009.12.062. Epub 2010 Jan 5. Vaccine. 2010. PMID: 20056185

2

Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus.

Kortekaas J, Dekker A, de Boer SM, Weerdmeester K, Vloet RP, de Wit AA, Peeters BP, Moormann RJ. Kortekaas J, et al. Among authors: de boer sm, de wit aa. Vaccine. 2010 Mar 8;28(11):2271-6. doi: 10.1016/j.vaccine.2010.01.001. Epub 2010 Jan 14. Vaccine. 2010. PMID: 20079874

3

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.

Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, Moormann RJ. Kortekaas J, et al. Among authors: de boer sm. Vaccine. 2010 Jun 17;28(27):4394-401. doi: 10.1016/j.vaccine.2010.04.048. Epub 2010 Apr 29. Vaccine. 2010. PMID: 20434545

4

Efficacy of three candidate Rift Valley fever vaccines in sheep.

Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ. Kortekaas J, et al. Among authors: de boer sm. Vaccine. 2012 May 14;30(23):3423-9. doi: 10.1016/j.vaccine.2012.03.027. Epub 2012 Mar 24. Vaccine. 2012. PMID: 22449427

5

Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein.

van der Wal FJ, Achterberg RP, de Boer SM, Boshra H, Brun A, Maassen CB, Kortekaas J. van der Wal FJ, et al. Among authors: de boer sm. J Virol Methods. 2012 Aug;183(2):99-105. doi: 10.1016/j.jviromet.2012.03.008. Epub 2012 Mar 16. J Virol Methods. 2012. PMID: 22449758

6

Heparan sulfate facilitates Rift Valley fever virus entry into the cell.

de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ. de Boer SM, et al. Among authors: de haan ca. J Virol. 2012 Dec;86(24):13767-71. doi: 10.1128/JVI.01364-12. Epub 2012 Sep 26. J Virol. 2012. PMID: 23015725 Free PMC article.

7

Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

de Boer SM, Kortekaas J, Spel L, Rottier PJ, Moormann RJ, Bosch BJ. de Boer SM, et al. J Virol. 2012 Dec;86(24):13642-52. doi: 10.1128/JVI.01973-12. Epub 2012 Oct 3. J Virol. 2012. PMID: 23035232 Free PMC article.

8

New DIVA vaccine for the protection of poultry against H5 highly pathogenic avian influenza viruses irrespective of the N-subtype.

Peeters B, de Boer SM, Tjeerdsma G, Moormann R, Koch G. Peeters B, et al. Among authors: de boer sm. Vaccine. 2012 Nov 19;30(49):7078-83. doi: 10.1016/j.vaccine.2012.09.050. Epub 2012 Oct 2. Vaccine. 2012. PMID: 23036502

9

A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion.

Guardado-Calvo P, Atkovska K, Jeffers SA, Grau N, Backovic M, Pérez-Vargas J, de Boer SM, Tortorici MA, Pehau-Arnaudet G, Lepault J, England P, Rottier PJ, Bosch BJ, Hub JS, Rey FA. Guardado-Calvo P, et al. Among authors: de boer sm. Science. 2017 Nov 3;358(6363):663-667. doi: 10.1126/science.aal2712. Science. 2017. PMID: 29097548

10

Bunyaviruses: Expression of Recombinant Glycoproteins from Insect Cells.

De Boer SM. De Boer SM. Methods Mol Biol. 2025;2893:181-191. doi: 10.1007/978-1-0716-4338-9_14. Methods Mol Biol. 2025. PMID: 39671038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters